Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5806 AL 5820

[Cognitive-behavioral specialized units in Alzheimer disease treatment: a necessity]

Paccalin M.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Sep;10(3):233. doi: 10.1684/pnv.2012.0367.

Potential of drug-loaded nanoparticles for Alzheimer's disease: diagnosis, prevention and treatment

Doggui S, Dao L, Ramassamy C.

Ther Deliv. 2012 Sep;3(9):1025-7. doi: 10.4155/tde.12.84.

Effect of cholinesterase inhibitors on attention

Pepeu G, Giovannini MG, Bracco L.

Chem Biol Interact. 2013 Mar 25;203(1):361-4. doi: 10.1016/j.cbi.2012.09.016. Epub 2012 Oct 6.

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort

Wattmo C, Wallin AK, Minthon L.

BMC Neurol. 2012 Nov 5;12:134. doi: 10.1186/1471-2377-12-134.

Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial

Egefjord L, Gejl M, Møller A, Brændgaard H, Gottrup H, Antropova O, Møller N, Poulsen HE, Gjedde A, Brock B, Rungby J.

Dan Med J. 2012 Oct;59(10):A4519.

Effect of rhythmic auditory cueing on gait in people with Alzheimer disease

Wittwer JE, Webster KE, Hill K.

Arch Phys Med Rehabil. 2013 Apr;94(4):718-24. doi: 10.1016/j.apmr.2012.11.009. Epub 2012 Nov 13.

New horizons for diagnostics and therapeutic applications of graphene and graphene oxide

Feng L, Wu L, Qu X.

Adv Mater. 2013 Jan 11;25(2):168-86. doi: 10.1002/adma.201203229. Epub 2012 Nov 19.

[Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease]

Andrieux K, Couvreur P.

Biol Aujourdhui. 2012;206(3):185-90. doi: 10.1051/jbio/2012019. Epub 2012 Nov 22.

Application of behavior-based ergonomics therapies to improve quality of life and reduce medication usage for Alzheimer's/dementia residents

Mowrey C, Parikh PJ, Bharwani G, Bharwani M.

Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):35-41. doi: 10.1177/1533317512467678. Epub 2012 Nov 29.

4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy JP; CCCDTD4 participants.

Can J Neurol Sci. 2012 Nov;39(6 Suppl 5):S1-8. doi: 10.1017/s0317167100015183.

[Alzheimer's disease: are non-steroidal anti-inflammatory drugs effective?]

Peters O.

Dtsch Med Wochenschr. 2012 Dec;137(50):2627. doi: 10.1055/s-0032-1329138. Epub 2012 Dec 5.

[Assessment of benefits of drug therapies: memantine for Alzheimer's disease as an example]

Rüther E, Hellweg R, Janetzky W.

Fortschr Neurol Psychiatr. 2012 Dec;80(12):694-9. doi: 10.1055/s-0032-1312976. Epub 2012 Dec 10.

Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease

Chaudhary S, Scouten A, Schwindt G, Janik R, Lee W, Sled JG, Black SE, Stefanovic B.

J Magn Reson Imaging. 2013 Jul;38(1):26-35. doi: 10.1002/jmri.23967. Epub 2012 Dec 13.

Cognitive intervention therapy as treatment for behaviour disorders in Alzheimer disease: evidence on efficacy and neurobiological correlations

García-Alberca JM.

Neurologia. 2015 Jan-Feb;30(1):8-15. doi: 10.1016/j.nrl.2012.10.002. Epub 2012 Dec 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias